GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.
Kelestimur. Fahrettin F; Popovic. Vera V; Leal. Alfonso A; Van Dam. P Sytze PS; Torres. Elena E; Perez Mendez. Luisa F LF; Greenman. Yona Y; Koppeschaar. Hans P F HP; Dieguez. Carlos C; Casanueva. Felipe F FF
Key Findings
- Higher body fat (obesity) cuts the GH peak from the GHRH + GHRP‑6 test by about 25%.
- For BMI ≤ 35 the standard GH peak cut‑offs (≥20 µg/L normal, ≤10 µg/L deficient) still work.
- For BMI > 35 the cut‑offs should be shifted down by 5 µg/L (≥15 µg/L normal, ≤5 µg/L deficient).
Practical Outcomes
- If you’re using GHRP‑6 to boost GH, expect a smaller surge if you’re obese, especially with BMI > 35. You may need to adjust your dose or combine it with weight‑loss strategies to achieve the desired GH response. Also, when interpreting any GH‑stimulating test results, use the lower cut‑offs for high‑BMI individuals.
Summary
The study shows that people who are overweight or obese get a weaker growth‑hormone boost from the GHRH + GHRP‑6 test, and that the usual lab cut‑offs for judging a good or bad response need to be lowered for those with a BMI over 35.
Abstract
Obesity is characterized by low basal levels of growth hormone (GH) and impeded GH release. However, the main problem arises in the diagnosis of GH deficiency in adults, as all accepted cut-offs in the diagnostic tests of GH reserve are no longer valid in obese subjects. In this work, the role of obesity in the GH response elicited by the GHRH + GHRP-6 test was assessed in a large population of obese and nonobese subjects. GHRH + GHRP-6-induced GH peaks were evaluated in 542 subjects. One hundred and five were healthy obese, 50 were morbid obese, and 261 were nonobese (both normal weight and overweight). One hundred and seventy-six GH-deficient patients (obese and nonobese) were also studied. A regression analysis of the 366 subjects with normal pituitary function indicated that adiposity had a negative effect on the elicited GH peak (r = -0.503, P < 0.0001). A receiver operating characteristic (ROC) curve analysis showed that in subjects with a BMI < or =35, the currently accepted cut-offs of the GHRH + GHRP-6 test (GH peaks > or =20 microg/l: normal secretion; GH peaks < or =10 microg/l: GH deficiency), were fully operative. However, in subjects with a BMI > 35, normality was indicated by GH peaks > or =15 microg/l and GH deficiency by peaks < or =5 microg/l (1 microg/l = 2.6 mU/l). This study confirms: (a) that the combined provocative test is adequate to separate normal and GH-deficient subjects; (b) the negative effect of obesity on GH secretion; (c) that obesity accounts for 25% of the reduction of GH release; and (d) that present cut-off values are applicable to normal weight, overweight and grade I obesity subjects, whereas in obese subjects with a BMI exceeding 35, all the normative limits of the GHRH-GHRP +6 test must be reduced by 5 microg/l.
Study Information
pubmed
2006
2006-06-01T00:00:00.000Z
10.1111/j.1365-2265.2006.02525.x
43
33